Kyle Mikson
Stock Analyst at Canaccord Genuity
(3.56)
# 867
Out of 5,138 analysts
120
Total ratings
45.16%
Success rate
8.2%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings | Maintains: Buy | $160 → $170 | $99.68 | +70.55% | 3 | Dec 22, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $19 → $20 | $22.05 | -9.30% | 10 | Dec 22, 2025 | |
| TEM Tempus AI | Maintains: Buy | $95 → $80 | $66.78 | +19.80% | 3 | Dec 22, 2025 | |
| QTRX Quanterix | Maintains: Hold | $5 → $8 | $7.02 | +13.96% | 8 | Dec 22, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $2 → $1.5 | $1.19 | +26.05% | 6 | Dec 22, 2025 | |
| NTRA Natera | Maintains: Buy | $250 → $285 | $234.85 | +21.35% | 12 | Dec 22, 2025 | |
| ILMN Illumina | Maintains: Hold | $112 → $130 | $147.17 | -11.67% | 14 | Dec 22, 2025 | |
| GH Guardant Health | Maintains: Buy | $100 → $125 | $114.87 | +8.82% | 10 | Dec 22, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $37 → $50 | $40.85 | +22.40% | 6 | Dec 22, 2025 | |
| CAI Caris Life Sciences | Maintains: Hold | $28 → $30 | $26.27 | +14.20% | 2 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $85 → $105 | $102.30 | +2.64% | 10 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $105 | $101.34 | +3.61% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $40 → $43 | $41.69 | +3.14% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $150 → $165 | $163.33 | +1.02% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $4.74 | +216.79% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $20 | $8.92 | +124.22% | 5 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $2.36 | +27.12% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.21 | +147.93% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.32 | +529.13% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,476 | $6.19 | +23,744.91% | 1 | Mar 30, 2021 |
GeneDx Holdings
Dec 22, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $99.68
Upside: +70.55%
10x Genomics
Dec 22, 2025
Maintains: Buy
Price Target: $19 → $20
Current: $22.05
Upside: -9.30%
Tempus AI
Dec 22, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $66.78
Upside: +19.80%
Quanterix
Dec 22, 2025
Maintains: Hold
Price Target: $5 → $8
Current: $7.02
Upside: +13.96%
Quantum-Si incorporated
Dec 22, 2025
Maintains: Hold
Price Target: $2 → $1.5
Current: $1.19
Upside: +26.05%
Natera
Dec 22, 2025
Maintains: Buy
Price Target: $250 → $285
Current: $234.85
Upside: +21.35%
Illumina
Dec 22, 2025
Maintains: Hold
Price Target: $112 → $130
Current: $147.17
Upside: -11.67%
Guardant Health
Dec 22, 2025
Maintains: Buy
Price Target: $100 → $125
Current: $114.87
Upside: +8.82%
Castle Biosciences
Dec 22, 2025
Maintains: Buy
Price Target: $37 → $50
Current: $40.85
Upside: +22.40%
Caris Life Sciences
Dec 22, 2025
Maintains: Hold
Price Target: $28 → $30
Current: $26.27
Upside: +14.20%
Nov 25, 2025
Downgrades: Hold
Price Target: $85 → $105
Current: $102.30
Upside: +2.64%
Nov 17, 2025
Maintains: Buy
Price Target: $85 → $105
Current: $101.34
Upside: +3.61%
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $41.69
Upside: +3.14%
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $163.33
Upside: +1.02%
Oct 27, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $4.74
Upside: +216.79%
Sep 19, 2025
Maintains: Buy
Price Target: $30 → $20
Current: $8.92
Upside: +124.22%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $2.36
Upside: +27.12%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.21
Upside: +147.93%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.32
Upside: +529.13%
Mar 30, 2021
Initiates: Overweight
Price Target: $1,476
Current: $6.19
Upside: +23,744.91%